帕博利珠单抗联合二甲双胍治疗转移性头颈部癌的 II 期可行性研究
A Phase II Feasibility Study Combining Pembrolizumab and Metformin in Patients with Metastatic Head and Neck Cancer.
二甲双胍联合帕博利珠单抗耐受性良好,仅出现轻度胃肠道不良事件,并展现出有前景的活性,值得在随机试验中进一步研究。
英文原题:The impact of the tumor immune microenvironment and tumor-infiltrating lymphocyte subgroups on laryngeal cancer prognosis.
The impact of the tumor immune microenvironment and tumor-infiltrating lymphocyte subgroups on laryngeal cancer prognosis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
这些发现提示,增强 CD3、CD20 和 CD4 淋巴细胞的浸润可能是一种值得在临床试验中探索的治疗策略。
喉癌生存率长期未见改善,推动了对肿瘤免疫反应的研究。头颈癌的免疫微环境和免疫浸润参与疾病发生发展。本研究分析50例接受喉切除的喉鳞癌患者组织中CD3、CD20、CD8、CD4、CD25和FoxP3阳性TIL亚群及其预后影响。CD3、CD20和CD4细胞浸润较高与疾病特异性、无病及无复发生存改善相关;CD3和CD4高浸润还与总生存期改善相关。CD8、FoxP3和CD25表达与生存指标无显著关联。提示CD3、CD20和CD4阳性细胞所反映的强抗肿瘤免疫反应是有利预后因素,增强这些淋巴细胞浸润值得临床试验探索。
The absence of improvement in survival rates across various cancers, including laryngeal cancer, has led to an increasing interest in understanding the immune response to cancer. In head and neck cancers, immune modulatory mechanisms such as immune microenvironment and immune infiltration are important in cancer pathogenesis. This study aims to explore the distribution of tumor-infiltrating lymphocyte (TIL) subgroups in the immune microenvironment and evaluate their impact on tumor histopathological characteristics and prognosis. The study included 50 patients who underwent laryngectomy for laryngeal squamous cell carcinoma, in Istanbul University - Cerrahpa a, Faculty of Medicine Department of Otorhinolaryngology, between January 2016 and January 2018. Pathology specimens were evaluated using immunohistochemistry to assess the expressions of the CD3, CD20, CD8, CD4, CD25, and FoxP3 markers, identifying subgroups of TILs. The investigation aimed to uncover how these subgroups influence tumor histopathological features and survival outcomes. The high infiltration of CD3, CD20, and CD4 had a positive impact on disease-specific survival, disease-free survival, and recurrence-free survival. In addition, overall survival was positively affected by high CD3 and CD4 infiltrations. However, no significant relationship was observed between the expressions of CD8, FoxP3, and CD25 and any of the survival parameters. The infiltration of CD3, CD20, and CD4 positive cells indicative of a robust antitumoral immune response-emerged as favorable prognostic factors in laryngeal cancer. These findings suggest that enhancing the infiltration of CD3, CD20, and CD4 lymphocytes could be a therapeutic strategy worth exploring in clinical trials.
MEMBER ACCOUNT
登录成功会直接打开下一页。